Reed Smith’s Life Sciences Health Industry Group will be hosting an upcoming CLE webinar, “Hosting and Managing User Generated Content (UGC)” on Thursday, January 19, 2017 at 12 p.m. ET. This webinar will address the legal liability and responsibility of a drug or device company that incorporating any user generated content (UGC) features on websites or within social media channels owned or controlled by the company.
Among other things, attendees will learn about the Communications Decency Act (CDA), a federal law that makes an Internet service provider immune from liability related to UGC under many circumstances, as long as the provider is not controlling the statements to such a degree it makes them its own. FDA policy, and statements regarding the CDA and social media will also be explored, as well as the interplay between the CDA and the Food, Drug, and Cosmetic Act.
This program is free and presumptively approved for 1.5 general CLE credit in California, Illinois, New Jersey, Pennsylvania, Texas and West Virginia. For lawyers licensed in New York, this course is eligible for 1.5 credit under New York’s Approved Jurisdiction Policy.
You can register by clicking here.
